Abstract:
The present invention includes a method for the treatment of myeloma comprising identifying a patient with myeloma and administering to the patient a synergistic, effective amount of a truncated, dominant negative form of Galectin-3 and a proteasome inhibitor.
Abstract:
The present invention includes a method for the treatment of an advanced ovarian cancer, comprising: identifying a patient with advanced ovarian cancer; and administering to the patient an effective amount of truncated, dominant negative form of Galectin-3 sufficient to reduce the advanced ovarian cancer. In certain aspects, the truncated, dominant negative form of Galectin-3 is provided in an amount sufficient to reduce at least one of growth, motility, invasion, angiogenesis, or prevents Akt/NF-ĸΒ activation of the ovarian cancer.
Abstract:
Disclosed is an invention of cotton lines 2-340/1-422, 1-422/SCM 3-7-3, 1-422/2-340, 1-136/2-340, AFIS 1-422, AFIS 2-340, AFIS 1-136, and SCM 3-7-3, and relates to seeds, plants, plant cells, plant tissue and harvested products, lint, and oil, as well as to hybrid cotton plants and seeds and other plants, cultivars, and varieties produced by essentially deriving such plants, cultivars, and varieties from cotton lines 2-340/1-422, 1-422/SCM 3-7-3, 1-422/2-340, 1-136/2-340, AFIS 1-422, AFIS 2-340, AFIS 1-136, and SCM 3-7-3. The present invention particularly relates to the development of specific cotton lines for the regulation of palmitic acid for the production of seeds having cottonseed oil content with reduced levels of palmitic acid. The cotton lines of the present disclosure have lower levels of palmitic acid content, and allows for the germination of seed at lower soil temperatures than current commercially available cotton cultivars.
Abstract:
An aerodynamic or hydrodynamic wall surface has an array of fibrillar structures disposed on and extending from the wall surface, wherein each fibrillar structure comprises a stalk and a tip. The stalk has a first end and a second end, wherein the first end is attached to the wall surface, and the stalk is oriented with respect to the wall surface at a stalk angle between approximately 1 degrees and 179 degrees. The tip has a first side and a second side, wherein the first side is attached proximate to the second end of the stalk, the tip has a larger cross-sectional area than the stalk, and the second side comprises a substantially planar surface that is oriented with respect to the stalk at a tip angle between approximately 0 degrees and 90 degrees.
Abstract:
The present invention includes compositions and methods for improving a cytotoxic immune response to a cancer antigen comprising obtaining peripheral blood mononuclear cells from a subject; incubating adherent peripheral blood mononuclear cells with the cancer antigen and GM-CSF in the absence of IL-4 to mature the adherent peripheral blood mononuclear cells into dendritic cells; and isolating the matured dendritic cells, wherein the matured dendritic cells stimulate cytotoxic T cells specific for the cancer antigen in vivo.
Abstract:
The present invention includes compositions and method of selectively modulating an intramuscular adipose tissue in beef cattle by providing a beef cattle and providing a pharmacologically effective amount of one or more agents that interact with a GPR43 receptor in the beef cattle, wherein the one or more agents modulate the GPR43 receptor to preferentially enhance the development of an intramuscular adipose tissue in the beef cattle but has no effect on subcutaneous adipose tissue accumulation in the beef cattle.
Abstract:
Illustrative embodiments of methods and apparatus for identifying one or more intact glycopeptides in a sample are disclosed. According to one illustrative embodiment, a method may comprise receiving data representing a plurality of mass spectra obtained from mass spectrometry of the sample, scoring data representing each of the plurality of mass spectra against data associated with target glycopeptides, and identifying one or more intact glycopeptides in the sample based at least in part on the scoring of the data representing each of the plurality of mass spectra.
Abstract:
Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
Abstract:
The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: attaching to a T Cell receptor mimic (TCR mimic) an active agent to form a therapeutic agent; and administering to the subject the therapeutic agent in a pharmaceutically acceptable carrier, wherein the therapeutic agent effectively crosses the EC microvascular barrier. Furthermore, the present invention relates to methods of treating diseases (particularly neuronal diseases) or conditions comprising identifying a subject in need of such a treatment and administering to said subject a composition comprising a TCR mimic conjugated to an active agent.
Abstract:
Disclosed are high density lipoprotein-nucleic acid particles, wherein the particles include (a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region, wherein the positively-charged region of the polypeptide associates with the nucleic acid component. Also disclosed are pharmaceutical compositions that include a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region. Methods that concern the particles and pharmaceutical compositions of the present invention are also set forth, as well as kits.